Becton, Dickinson and Company (BDX)

NYSE · Healthcare · Medical Instruments & Supplies
$212.78+0.05%As of 2026-11-22 · USD
Last session low $211.32Last session high $216.52
52-week low $140.1152-week high $220.36
Market cap
$57.96B
Sector
Healthcare
P/E (TTM)
42.1x
Dividend yield
1.99%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)64.7In the neutral range (30 to 70)
MACD (12, 26, 9)6.38Below its signal line (6.75); histogram -0.37
Bollinger %B (20, 2)63%Inside the bands (191.38 to 225.14)
SMA 20208.26Price is 2.2% above
SMA 50194.47Price is 9.4% above
SMA 200170.18Price is 25.0% above
ATR (20)2.11% of priceAverage true range per day
52-week position91%In the upper part of the 140.11 to 220.36 range

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

Insider filings, 90 daysNo purchases and 3 sales (about $60K).
Latest fiscal yearEnded 2025-09-30: revenue of $21.84B and an operating margin of 13.7%.

More in Medical Instruments & Supplies